📢Rare doesn’t mean invisible. On #BPDCNDay, we raise awareness of #BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) and stand with the community calling for earlier diagnosis and better care. ➡️Learn more: lnkd.in/eSRCq8nM 🔗Watch our video: www.linkedin.com/feed/update/...

📣CPE took part in the webinar “Interferencia de la Industria del #Tabaco en #España: Evidencias, Desafíos y Respuestas”, highlighting how tobacco industry interference continues to undermine public health policies. 🔗 The recording is now available here: lnkd.in/enC8RrkG

📅 SAVE THE DATE Join us to explore the results of our pan-European survey on nutritional support for cancer patients and survivors. 🗓️ 3 February 2026, 17:00 – 19:00 CET 📍European Parliament, SPINELLI A8F388 ➡️ Register here: lnkd.in/epDRmxgf

📢 Register for the INSPIRE Project Final Symposium 📅 16 May 2026 📍 Prague | O₂ Universum 🕑 14:00–17:00 CET ➡️ Register now: lnkd.in/eT4puc2F 🔗 Learn more about the event: lnkd.in/en8hHmFF

🌐 Don't miss the Mission Early's webinar on “Defining the ideal framework for early cancer care – key takeaways from WCLS and next steps” 🗓️26 January 2026 ⏰2.30-3.30 pm CET ➡️ Register here: lnkd.in/evdCW6Yy

🌟 CPE is proud to support My Cancer Navigator! Offered by the Anticancer Fund, My Cancer Navigator provides trusted guidance for patients, families, and healthcare professionals navigating cancer care. 🔗Learn more: mycancernavigator.org/en

📢 Reflecting on One Year of EU HTA Regulation: The Patient Perspective CPE participated in the @eupatientsforum.bsky.social webinar “One Year of HTA Regulation Implementation – What Has Changed for Patients?” ➡️ Read more: lnkd.in/eG4vaAgq

🚭 Webinar | Interferencia de la industria del tabaco en España Nuestro presidente, @frguez.bsky.social, aportará la perspectiva de los pacientes. 📅 16 de enero de 2026 | ⏰ 14:00 CET ➡️ Inscripción: lnkd.in/emfTWY4G

✨Our December newsletter is here! As we look ahead, we wish all our members and partners a healthy, hopeful, and successful New Year. 📩 Read the latest updates: lnkd.in/epb2BTZE 🔔 Subscribe to CPE’s newsletter and stay informed: lnkd.in/eDvSftYT

📢 Report Now Available! CPE and @pce-europe.bsky.social hosted a webinar exploring how the new #EUHTA Regulation can help bridge the gap between policy and real-world access to innovative therapies. 📄 The full report is now available: lnkd.in/enG5RNzz

🎄Season’s greetings from all of us at CPE! As the year draws to a close, we would like to thank our members, partners, and friends for your continued collaboration and support throughout the past year. 🔗Watch our video: youtu.be/1BCpDAV0fRU

📢 Tackling Cancer Inequalities Through Innovation in Europe ➡️ Read more: lnkd.in/eknRVSHR

📢¡No te pierdas este webinar! 📅 Viernes 16 de enero de 2026 ⏰ 14:00 h (CET) ➡️ Inscríbete ahora: lnkd.in/emfTWY4G Para más información, consulta el siguiente enlace: lnkd.in/ej7iHUEN

📢 20 Years of Tobacco Control Insightful interview with our Chair of the Board @frguez.bsky.social reflecting on two decades of anti-tobacco legislation in #Spain and the urgent need to strengthen cancer prevention policies across Europe. 🔗 Watch the full interview: youtu.be/QYszQ3A3nJY?...

📢Register now for the INSPIRE final symposium! 📅 16 May 2026 📍 Prague | O₂ Universum 🕑 14:00–17:00 CET 🔗 Registration is free and open: lnkd.in/dxgsncWU ➡️ Read more about INSPIRE event: lnkd.in/en8hHmFF

📢 CPE welcomes #EPPerMed's decision to allocate dedicated funding for patient organisations 🔗 Read more: lnkd.in/edHVvJcZ ➡️ Learn more about EP PerMed: eppermed.eu

📢 CPE at the 7th European Cancer Forum in Brussels CPE highlighted the patient perspective, calling for a European Semester on cancer, robust data & meaningful patient involvement. 🔗Read more: lnkd.in/euF3QFMQCPE

📢 Advancing Cancer Policy CPE & EFPIA launched the EBCP-NCCP Implementation Study to drive real-world impact in national cancer strategies. 🔗 Learn more: lnkd.in/et2bnmgu ➡️ Read the Report: lnkd.in/ewXtTAdc

📢 CPE at the European Parliament: Highlighting the importance of patient perspectives in EU health policy. CPE continues to advocate for integrating patient voices in policy & care across Europe. 🔗Read more: lnkd.in/e-4fETVy

📢 CPE at the European Health Summit 2025 🔗 Learn more: lnkd.in/e4YXsPjf 📄 Read our European Semester Manifesto: lnkd.in/e4YXsPjf

📢 CPE at #WCLS2025 CPE remains committed to keeping the patient voice central in cancer policy, advocating for coordinated action, equitable access, and meaningful community engagement. 🔗 Learn more: lnkd.in/dMtgD4Gc

📢 Join us on 1 December (14:00–15:00 CET) for the launch of our new report co-authored with the EFPIA - European Federation of Pharmaceutical Industries and Associations Oncology Platform. ➡️ Register here: lnkd.in/d5cSz_d2

📢 CPE at the European Huntington Association (EHA) Workshop: Ensuring Meaningful Patient Involvement in EU HTA Processes ➡️ Read more: lnkd.in/dQMjBYKP

🩺 #EHS2025: Panel Announcement "Investing in Health: The Case for Smarter Economies & Healthier Futures". 🗣Featuring speakers from Minister for Health and Active Ageing -Government of Malta, Pfizer, Astellas, @eib.org, and @cancerpatientseu.bsky.social. Register now: ebsummits.eu/our-summits/...

📢 We’re Hiring! CPE is looking for an Events Officer to join our team in the heart of Brussels! 📆 Apply by December 19th, 2025 ➡️ Details and application: lnkd.in/dmWh2vqA

➡️Don’t Miss It! 🗓 Date: Thursday, 27 November 2025 🕞 Time: 15:30 – 17:00 CET 📍 Location: Online

📢Perception of Targeted Radiotherapy in Europe. Your Experience Matters! ➡️Take the survey: lnkd.in/di7nW5cr 🔗Learn more: lnkd.in/di7nW5cr

"Around 50% of cancer deaths are linked to infection, and mortality rises sharply when those infections are resistant." ➡️CPE will continue pushing to make #AMR a central priority in cancer policy across Europe. 🔗 Read more: lnkd.in/dcX-75WN

🎗️ #LungCancerAwarenessMonth - Support Matters! This November, CPE is proud to support @lungcancereurope.bsky.social 2025 #GetSupported campaign, focusing on the essential support patients need after diagnosis. 🔗 Learn more: getchecked.eu

📢 #AMR Awareness Week: Why Antibiotics Matter for Cancer Patients 🔗Read more: lnkd.in/dwKuha3D

📢 CPE at the European Health Workforce and Care Strategy Forum in Brussels We believes that supporting the healthcare workforce is essential, because stronger professionals mean better care for patients. 🔗 Learn more: lnkd.in/d-eKtct9

📢 #AMR Awareness Week CPE will continue pushing for evidence-based, patient-led policies that safeguard the future of cancer treatment across Europe. 🔗 Read more: lnkd.in/dh2YJWyB

📢 World #AMR Awareness Week: A Life-Threatening Crisis for Cancer Patients Without effective antibiotics, there is no effective cancer care. 🔗 Learn more: lnkd.in/gSr6pN48 📰 Read more: lnkd.in/en9J9fUS

📢 CPE at #ISPOREurope 2025 CPE champions patient engagement, shared tools & capacity-building to ensure patients are equal partners in every stage of health tech assessment & clinical research. 🔗 Read More: lnkd.in/d7vVRFcd

🎗️November is #GastricCancerAwarenessMonth CPE proudly support @digestivecancerseu.bsky.social in their work to advance equitable access to high-quality cancer care and strengthen the voice of patients across Europe. 🔗 Learn more: lnkd.in/dKHmMEar

📢 CPE at the EU Life Science Strategy Roundtable in Copenhagen! CPE continues to push for meaningful patient involvement and tangible impact for all patients. 🔗Learn more: lnkd.in/dgvvYivX

14 November marks #WorldDiabetesDay. 🩺 Good nutrition is essential for managing diabetes and, as our survey shows, it’s too often overlooked in cancer care. Thank you to 2,500+ patients, survivors & carers who shared their experiences. 🔗 Learn more: lnkd.in/dEdgbNur

📢 CPE at the #EUHPP Live Webinar! CPE highlighted that patients must be active partners in EU Cancer Mission research to ensure real needs are met and innovation is patient-centred. ➡️ Read more on our full article: lnkd.in/dnf_y6Rj

📌 #SaveTheDate: 7th European Cancer Forum 2025 CPE is proud to support the 7th European Cancer Forum! 📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET 🔗 Registrations: lnkd.in/d8UatNRr ➡️ Read more: lnkd.in/d_x-ASw

📌CPE participated in the European Access Academy (EAA) Fall Convention 2025 in Paris! CPE is committed to embedding patient voices in Europe’s HTA to drive real impact. 🔗 Read more: lnkd.in/d-byCcSz 👉 Learn more: lnkd.in/diVgKTfa

📢 CPE joined the 1st EP PerMed Expert Symposium in Bilbao! CPE highlighted how patient advocacy and HTA can turn innovation into real impact. 🔗Read more: lnkd.in/daWrFUNh

📢 CPE at the Alira Health Webinar: Unlocking Patient Insights Through Meaningful Collaboration 🔗 Learn more: lnkd.in/dSUYFhNq

📢 Thank You for Sharing Your Voice! CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies. 🔗 Read more: lnkd.in/d2ws7uzu

#GlobalBiosimilarsWeek 2025 comes to an end! 💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care. 🔗Read more: lnkd.in/dNegRwWS ➡️Learn more: lnkd.in/dpKUummP

📢 Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy: CPE’s High-Level Policy Event at the European Parliament. 🔗 Learn more: lnkd.in/dpKUummP

📢 Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients. CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access. 🔗Learn more: lnkd.in/dFTK83eh

🎙️ Don’t miss it! Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”. 🗓️Thursday, 6 November 2025 🕔 4:00–5:30 PM CET ➡️Learn more: lnkd.in/d7M4z2Ur

📢 Advancing Equity and Patient Voice in Cancer Care: Spain’s Response to the EU HTA Regulation 🔗 Read more about the event in our article: lnkd.in/d-XZJreU

🏥Los medicamentos biosimilares han ayudado a millones de pacientes a luchar contra el cáncer. Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles. El acceso es la clave. 🗣️ @nicogcasares.bsky.social 🇪🇺 @cancerpatientseu.bsky.social

🚀 Happening Now at the European Parliament! Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy. 🔗 Learn more here: lnkd.in/dgsRSmp3